Skip to main content
Figure 4 | BMC Pulmonary Medicine

Figure 4

From: Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD

Figure 4

Change in SGRQ. (a) Change from baseline in SGRQ total score; (b) Change from baseline in SGRQ total score in the ITT population with FEV1 < 50% of predicted normal value. SGRQ, St. George Respiratory Questionnaire; BDP/FF, beclomethasone dipropionate/formoterol fumarate; FP/S, fluticasone propionate/salmeterol. p > 0.05 (not significant) for differences between BDP/FF and FP/S both in the general and in the FEV1 < 50% of predicted normal value population. P values shown refer to change from baseline: ***p < 0.001, and *p = 0.01.

Back to article page